AM

Healthcare · Pharmaceuticals

Amanta Healthcare Ltd (AMANTA)

₹218.00

Mkt cap
₹864 Cr
P/E ratio
47.10
P/B
3.71
Div yield
0.00%
ROE
10.30%
ROCE
11.60%
EPS (TTM)
₹4.63
Book value
₹59
52W range
92–246
Sector
Healthcare

Price history

Previous close

Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products. [1]

NSE AMANTABSE 544502
Health check
Mixed
ValuationExpensive
ProfitabilityAverage
GrowthModerate
TechnicalsBullish
52-week range
−11.27% from high
₹218
₹92+136.96% from low₹246
Current
₹218.00
Prev close
₹239.08
Day
−8.82%
Price performance
1D
−8.82%
1W
−7.02%
1M
+32.22%
3M
+16.88%
6M
+72.69%
1Y
+81.94%
YTD
+98.65%

Financials

Revenue, profit & margin
P/E ratio
47.1×
AMANTA is 45% above the sector median of 32.5×
AMANTA47.1×
Sector median32.5×
 Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales68.1066.7367.8172.0665.3170.8974.4976.9968.8083.13
YoY Sales growth-4.10%+6.23%+9.85%+6.84%+5.34%+17.27%
Expenses54.7052.8552.7553.1050.4156.2459.1362.0354.2665.94
Operating Profit13.4013.8815.0618.9614.9014.6515.3614.9614.5417.19
OPM %19.68%20.80%22.21%26.31%22.81%20.67%20.62%19.43%21.13%20.68%
Other Income0.150.210.870.160.96-2.560.681.660.640.76
Interest9.456.325.906.286.295.155.064.256.005.84
Depreciation4.604.604.514.694.644.664.674.754.695.28
Profit before tax-0.503.175.528.154.932.286.317.624.496.83
Tax %-28.00%28.71%22.64%26.87%28.80%46.93%26.47%27.43%26.28%28.84%
Net Profit-0.362.264.285.963.511.214.635.533.314.86
EPS in Rs-0.120.781.482.071.220.311.191.420.851.25
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +2.60% · closed higher next day 1 of last 2
 Q1FY27†Q2FY27
Broadcast5 Aug '26◦3 Nov '26◦
Earnings day−2.00%+7.21%
+1 day−3.96%+13.71%
+5 days−11.40%+32.40%
+15 days+8.21%—
+30 days+9.80%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
63.80%Promoter
Promoters63.80%
FIIs0.07%0.36
DIIs12.20%0.72
Public23.93%1.09
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,884.9036.704,51,5380.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,180.5086.862,96,8070.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,689.5082.071,78,1800.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,294.6092.691,24,1950.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,200.0026.481,19,9900.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,390.2041.561,16,3600.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,415.0036.881,14,5180.92%852−35.05%7,404−2.44%15.49%
Amanta Healthcar₹222.3747.138640.00%5+159.89%83+17.27%11.60%
Median: 160 Co.₹432.2032.471,9870.08%13+33.73%179+21.23%14.94%

Filings